**Core Concept**
The Revised National Tuberculosis Control Programme (RNTCP) outlines treatment regimens for multidrug-resistant tuberculosis (MDR TB), focusing on second-line drugs due to resistance to first-line drugs like **isoniazid** and **rifampicin**.

**Why the Correct Answer is Right**
The correct answer is based on the standard RNTCP regimen for MDR TB, which typically includes **kanamycin**, **levofloxacin**, **ethionamide**, **pyrazinamide**, and **cycloserine**, among others.

**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because it might be a part of the regimen.
**Option B:** Incorrect as it could be included in some MDR TB treatment protocols.
**Option C:** Incorrect as this might also be used in certain cases of MDR TB.

**Why Each Wrong Option is Incorrect (Continued)**
**Option D:** This is the correct choice as it is not typically included in the RNTCP regime for MDR TB, but without the specific drug names, we can't provide a detailed explanation for each option.

**Clinical Pearl / High-Yield Fact**
Remember, MDR TB treatment regimens are complex and based on drug susceptibility testing. Always refer to the latest guidelines for specific drug combinations.

**Correct Answer:** D. Thiacetazone